Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:28 PM
Ignite Modification Date:
2025-12-24 @ 5:28 PM
NCT ID:
NCT00234468
Eligibility Criteria:
Inclusion Criteria:
* Histologically Confirmed Non Small Cell Lung Cancer.
* Locally advanced disease previously treated with combined therapy (chemotherapy and surgery with or without radiotherapy, or chemotherapy and radiotherapy).
* Chemotherapy with regimens containing cisplatin or carboplatin is mandatory
* Response to combined therapy
Exclusion Criteria:
* No previous treatment with ZD1839 or any other EGFR-targeted therapy
* No progressive disease after combined therapy for locally advanced NSCLC
* No presence of metastatic disease
* No other co-existing malignancies or malignancies diagnosed within the last 5 years with the exception of basal cell carcinoma or cervical cancer in situ
* Any unresolved chronic toxicity from previous anticancer therapy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00234468
Study Brief:
Protocol Section:
NCT00234468